Gain-of-function mutations in either KCNQ1 or KCNE1 genes shorten the action potential duration and effective refractory period in cardiomyocytes, increasing the risk of atrial fibrillation (AF) [8, 9]. This evidence concerns the gene KCNE1 and atrial fibrillation.